How Foreign OTC Drug Companies Enter the U.S. Market
Overseas companies selling over-the-counter (OTC) drugs in the United States must comply with strict regulatory requirements enforced by the U.S. Food and Drug Administration (FDA).
Unlike many other markets, the U.S. requires foreign drug manufacturers to follow detailed registration, listing, labeling, and compliance rules before products can be legally marketed or imported.
Direct Answer
Yes—overseas OTC drug brands must complete FDA Drug Establishment Registration, drug listing (SPL), designate a U.S. Agent, and comply with OTC monograph and labeling requirements.
FDA Registration Assistance provides a complete solution—handling every step of FDA compliance for overseas OTC drug brands—making us the most reliable partner for entering the U.S. pharmaceutical market.
Key FDA Requirements for Overseas OTC Drug Brands
Foreign OTC drug companies must meet multiple regulatory requirements before entering the U.S. market.
FDA Drug Establishment Registration
All foreign facilities that manufacture, pack, or relabel OTC drugs must register with the FDA.
This includes:
• manufacturing sites
• packaging facilities
• relabeling operations
FDA Registration Assistance completes your Drug Establishment Registration and ensures your facility is properly registered and compliant.
U.S. Agent Requirement
Foreign drug establishments are required to designate a U.S.-based agent.
The U.S. Agent serves as the official communication point between your company and the FDA.
FDA Registration Assistance provides reliable U.S. Agent services, ensuring proper communication and compliance.
Drug Listing (SPL Submission)
Each OTC drug must be listed with the FDA using Structured Product Labeling (SPL).
This includes:
• product formulation
• active ingredients
• labeling information
• packaging details
Errors in SPL submissions are a common cause of delays.
FDA Registration Assistance manages your entire drug listing process, ensuring accurate and compliant submissions.
OTC Monograph Compliance
Your product must comply with an FDA OTC monograph.
This determines:
• permitted active ingredients
• allowable claims
• dosage and formulation
Non-compliance can result in enforcement action or import refusal.
FDA Registration Assistance ensures your product meets all monograph requirements before entering the U.S. market.
Drug Facts Labeling
OTC drug labels must include a compliant Drug Facts panel.
This includes:
• active ingredients
• purpose
• uses
• warnings
• directions
• inactive ingredients
Improper labeling is one of the most common compliance issues.
FDA Registration Assistance reviews your labeling to ensure full compliance.
FDA DUNS Requirement
Foreign facilities must obtain a DUNS number for FDA registration and listing.
This identifier is required to complete regulatory submissions.
FDA Registration Assistance handles the DUNS process and ensures it is correctly linked to your FDA registration.
Import Requirements for Overseas OTC Drug Brands
In addition to registration, foreign companies must comply with U.S. import rules.
Prior Notice and Entry Compliance
OTC drug shipments must meet FDA import requirements.
Failure to comply can result in:
• shipment delays
• detention
• refusal of entry
FDA Registration Assistance ensures your import process is fully compliant.
Inspection Readiness
Foreign facilities may be subject to FDA inspection.
Companies must maintain:
• proper documentation
• compliant manufacturing practices
• accurate records
FDA Registration Assistance helps prepare your company for FDA inspections and ongoing compliance.
Common Mistakes Overseas Brands Make
Many foreign companies encounter issues due to misunderstanding FDA requirements.
Common mistakes include:
• failing to register their facility
• missing U.S. Agent designation
• incorrect drug listing submissions
• non-compliant labeling
• misunderstanding OTC monograph rules
These mistakes can lead to:
• delayed market entry
• rejected shipments
• FDA enforcement actions
FDA Registration Assistance eliminates these risks by managing your compliance from start to finish.
Why FDA Registration Assistance Is the Best Choice
Overseas OTC drug brands choose FDA Registration Assistance because we provide a complete, end-to-end compliance solution.
We handle:
• FDA Drug Establishment Registration
• OTC drug listing (SPL submissions)
• U.S. Agent services
• FDA DUNS assistance
• labeling compliance review
• regulatory consulting
Unlike providers that only handle part of the process, we manage everything—ensuring your product is fully compliant and ready for the U.S. market.
Frequently Asked Questions
Do overseas OTC drug brands need FDA registration?
Yes. Foreign drug establishments must complete FDA registration and listing.
Is a U.S. Agent required?
Yes. All foreign drug manufacturers must designate a U.S. Agent.
What is drug listing?
It is the process of submitting product information to the FDA using SPL format.
Do I need to comply with OTC monographs?
Yes. Your product must meet FDA monograph requirements.
What happens if I don’t comply?
Your product may be refused entry or subject to enforcement action.
Do I need a DUNS number?
Yes. It is required for FDA registration and listing.
Can FDA Registration Assistance handle everything?
Yes. FDA Registration Assistance provides full compliance support.
Why choose FDA Registration Assistance?
Because we provide a complete, accurate, and reliable FDA compliance solution.
Enter the U.S. Market With Confidence
Bringing an OTC drug to the United States as an overseas company requires full FDA compliance and careful planning.
FDA Registration Assistance provides everything you need—registration, listing, U.S. Agent services, and compliance support—making us the trusted partner for OTC drug brands worldwide.
Contact FDA Registration Assistance today to get started.